BioCentury
ARTICLE | Financial News

Silence Therapeutics proposes private placement of convertible notes

July 16, 2012 7:00 AM UTC

Silence Therapeutics plc (LSE: SLN), London, U.K. Business: Cancer, Renal, Ophthalmic Date announced: 7/12/12 Type: Private placement of convertible notes To be raised: £1 million ($1.5 million) Share...